2020 - Member of the National Academy of Medicine (NAM)
Jerry R. Mendell focuses on Internal medicine, Muscular dystrophy, Pathology, Duchenne muscular dystrophy and Endocrinology. His Internal medicine study incorporates themes from Gastroenterology, Surgery and Periodic paralysis. Jerry R. Mendell interconnects Limb-girdle muscular dystrophy, Anticipation, Clinical trial and Immunology in the investigation of issues within Muscular dystrophy.
The Pathology study combines topics in areas such as Peripheral neuropathy, Central nervous system and Anatomy, Nerve fiber. His Dystrophin and Duchenne dystrophy study, which is part of a larger body of work in Duchenne muscular dystrophy, is frequently linked to Eteplirsen, bridging the gap between disciplines. His Endocrinology research focuses on Muscle disorder and how it relates to Transgene.
Jerry R. Mendell mainly focuses on Duchenne muscular dystrophy, Muscular dystrophy, Internal medicine, Dystrophin and Pathology. His research on Duchenne muscular dystrophy also deals with topics like
His study on Internal medicine also encompasses disciplines like
His scientific interests lie mostly in Duchenne muscular dystrophy, Clinical trial, Internal medicine, Muscular dystrophy and Spinal muscular atrophy. He works on Duchenne muscular dystrophy which deals in particular with Dystrophin. Jerry R. Mendell has included themes like Endocrinology, Genetic enhancement and Cardiology in his Internal medicine study.
As a part of the same scientific study, he usually deals with the Endocrinology, concentrating on Gene delivery and frequently concerns with Gastrocnemius muscle. His work deals with themes such as Fibrosis, Vector, Adeno-associated virus and Skeletal muscle, which intersect with Muscular dystrophy. His research integrates issues of Gene replacement therapy, Anesthesia, Motor neuron and Phases of clinical research in his study of Spinal muscular atrophy.
Jerry R. Mendell spends much of his time researching Duchenne muscular dystrophy, Muscular dystrophy, Internal medicine, Genetic enhancement and Eteplirsen. His work in the fields of Dystrophin overlaps with other areas such as Vital capacity. Jerry R. Mendell focuses mostly in the field of Dystrophin, narrowing it down to matters related to Cancer research and, in some cases, Utrophin, Gene silencing and Morpholino.
The Muscular dystrophy study combines topics in areas such as Limb-girdle muscular dystrophy, Gene and Skeletal muscle. His Internal medicine study frequently links to adjacent areas such as Dysphagia. His Genetic enhancement research integrates issues from Endocrinology, Clinical trial, Bioinformatics, Dystrophy and Fibrosis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model
Janaiah Kota;Raghu R. Chivukula;Kathryn A. O'Donnell;Erik A. Wentzel.
Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
Jerry R. Mendell;Samiah Al-Zaidy;Richard Shell;W. Dave Arnold.
The New England Journal of Medicine (2017)
Inclusion body myositis and myopathies.
Robert C. Griggs;Valerie Askanas;Salvatore DiMauro;Andrew Engel.
Annals of Neurology (1995)
Evidence-based path to newborn screening for Duchenne muscular dystrophy.
Jerry R. Mendell;Chris Shilling;Nancy D. Leslie;Kevin M. Flanigan.
Annals of Neurology (2012)
Astrocytes from familial and sporadic ALS patients are toxic to motor neurons
Amanda M Haidet-Phillips;Mark E Hester;Carlos J Miranda;Kathrin Meyer.
Nature Biotechnology (2011)
The Survival Motor Neuron Protein in Spinal Muscular Atrophy
Daniel D. Coovert;Thanh T. Le;Patricia E. McAndrew;John Strasswimmer.
Human Molecular Genetics (1997)
Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver
Shu Hao Hsu;Bo Wang;Janaiah Kota;Jianhua Yu.
Journal of Clinical Investigation (2012)
Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria
Richard J. Barohn;John T. Kissel;John R. Warmolts;Jerry R. Mendell.
JAMA Neurology (1989)
Eteplirsen for the treatment of Duchenne muscular dystrophy
Jerry R. Mendell;Louise R. Rodino‐Klapac;Zarife Sahenk;Kandice Roush.
Annals of Neurology (2013)
Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy
J.R. Mendell;R.T. Moxley;R.C. Griggs;M.H. Brooke.
The New England Journal of Medicine (1989)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: